Skip to main content

Advertisement

SpringerLink
Log in

Orlistat for the long-term management of obesity

  • Clinical Trials Review
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anonymous: Update: Prevalence of overweight among children, adolescents, and adults — United States, 1988–1994. MMWR 1997, 46:199–202.

  2. Wolf.AM, Colditz GA: Current estimates of the economic cost of obesity in the United States. Obes Res 1998, 6:173–175.

    Google Scholar 

  3. Goldstein DJ: Beneficial health effects of modest weight loss. Int J Obes 1992, 6:397–415.

    Google Scholar 

  4. Sjostrom L, Rissanen A, Andersen T, et al., for the European Multicentre Orlistat Study Group: Randomised placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998, 352:167–173.

    Article  PubMed  CAS  Google Scholar 

  5. Davidson MH, Hauptman J, DiGirolamo M, et al.: Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999, 281:235–242.

    Article  PubMed  CAS  Google Scholar 

  6. Weber C, Tam YK, Schmidtke-Schrezenmeier G, et al.: Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers. Eur J Clin Pharmacol 1996, 51:87–90.

    Article  PubMed  CAS  Google Scholar 

  7. Hartmann D, Buzelhan C, Zuiderwijk PB, et al.: Lack of interaction between orlistat and oral contraceptives. Eur J Clin Pharmacol 1996, 50:421–424.

    Article  PubMed  CAS  Google Scholar 

  8. Melia AT, Mullign TE, Zhi J: The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers. J Clin Pharmacol 1996, 36:654–658.

    PubMed  CAS  Google Scholar 

  9. Zhi J, Melia AT, Guerciolini R, et al.: The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. J Clin Pharmacol 1996, 36:659–666.

    PubMed  CAS  Google Scholar 

  10. McCarthy WJ: Orlistat and weight loss [letter]. Lancet 1998, 352:1473.

    Article  PubMed  CAS  Google Scholar 

  11. Pace D, Guerciolini R, Wargovich M, et al.: Lack of effect of lipase inhibition with orlistat on colon cell turnover in obese subjects [abstract]. Int J Obes 1998, 22:S64.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk S40, 44195, Cleveland, OH, USA

    Douglas L. Seidner MD

Authors
  1. Douglas L. Seidner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seidner, D.L. Orlistat for the long-term management of obesity. Curr Gastroenterol Rep 1, 316–318 (1999). https://doi.org/10.1007/s11894-999-0115-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-999-0115-2

Keywords

Search

Navigation